Trial intelligence / Profile preview

Zoledronic acid versus tenofovir switch for low bone density in adults with HIV

ACTRN12612000776808Phase 4Completed

Sponsor
St. Vincent's University Hospital
Start
Jul 2012
Modality
Small Molecules
Countries
2
01

Overview

Phase 4, randomised, open-label trial of zoledronic acid, tenofovir, abacavir and raltegravir in osteopenia (2 arms), sponsored by St. Vincent's University Hospital. Started Jul 2012; status: completed.

02

Drugs

zoledronic acidtenofovirabacavirraltegravir
03

Conditions

osteopenia

Beyond the preview

Go deeper on ACTRN12612000776808.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12612000776808.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call